BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9164064)

  • 21. Reactivity of monoclonal antibodies EG1 and EG2 with eosinophils and their granule proteins.
    Nakajima H; Loegering DA; Kita H; Kephart GM; Gleich GJ
    J Leukoc Biol; 1999 Sep; 66(3):447-54. PubMed ID: 10496315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of eosinophil granule proteins in nasal mucosa of atopic patients with nasal polyposis.
    Min YG; Kim YJ; Yun YS
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(2):82-6. PubMed ID: 8736052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trial with a protease inhibitor gabexate mesilate in acute pancreatitis.
    Harada H; Miyake H; Ochi K; Tanaka J; Kimura I
    Int J Pancreatol; 1991; 9():75-9. PubMed ID: 1744450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gabexate mesilate improves pancreatic microcirculation and reduces lung edema in a rat model of acute pancreatitis.
    Chen HM; Shyr MH; Chen MF
    J Formos Med Assoc; 1997 Sep; 96(9):704-9. PubMed ID: 9308324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The protease inhibitor gabexate mesilate in experimentally-induced acute pancreatitis with early gram-negative infection in the Göttingen minipig: therapeutic efficacy and effects on blood coagulation and fibrinolysis].
    Heitz J; Semsch B; Emde C; Jansen U; Schäfer JH
    Z Gastroenterol; 1990 Apr; 28(4):192-7. PubMed ID: 2119091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect on hemodynamics of therapeutic infusion of gabexate mesilate (FOY) in experimental acute pancreatitis.
    Dobosz M; Sledziński Z; Basiński A; Stanek A; Babicki A; Wajda Z
    Res Exp Med (Berl); 1989; 189(2):77-84. PubMed ID: 2499022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
    Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
    Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome.
    Tajima K; Katagiri T
    Dig Dis Sci; 1996 Feb; 41(2):282-8. PubMed ID: 8601370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy of gabexate mesilate for acute pancreatitis in children.
    Kim SC; Yang HR
    Eur J Pediatr; 2013 Nov; 172(11):1483-90. PubMed ID: 23812506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis.
    Dabrowski A; Gabryelewicz A
    J Physiol Pharmacol; 1994 Sep; 45(3):455-65. PubMed ID: 7841457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of broncho-constriction induced by gabexate mesilate].
    Nomura M; Tanaka I; Fujimura M; Matsuda T
    Arerugi; 1996 Oct; 45(10):1133-6. PubMed ID: 8958661
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs.
    Luh SP; Tsai CC; Shau WY; Chen JS; Kuo SH; Lin-Shiau SY; Lee YC
    J Surg Res; 1999 Dec; 87(2):152-63. PubMed ID: 10600344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recurrent neutrophilic panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib mesilate and dasatinib].
    de Masson A; Bouvresse S; Clérici T; Mahé E; Saïag P
    Ann Dermatol Venereol; 2011 Feb; 138(2):135-9. PubMed ID: 21333826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of gabexate mesilate on serum inflammatory cytokines in rats with acute necrotizing pancreatitis.
    Chen CC; Wang SS; Tsay SH; Lee FY; Lu RH; Chang FY; Lee SD
    Cytokine; 2006 Jan; 33(2):95-9. PubMed ID: 16473521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis.
    Nakamura A; Yamazaki K; Suzuki K; Sato S
    Am J Gastroenterol; 1997 Dec; 92(12):2245-9. PubMed ID: 9399763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous regional arterial infusion therapy for acute necrotizing pancreatitis due to Mycoplasma pneumoniae infection in a child.
    Nakagawa M; Ogino H; Shimohira M; Hara M; Shibamoto Y
    Cardiovasc Intervent Radiol; 2009 May; 32(3):581-4. PubMed ID: 18956223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q
    BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.
    Freise J; Schmidt FW; Magerstedt P; Schmid K
    Clin Biochem; 1985 Aug; 18(4):224-9. PubMed ID: 2412725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasculitis in erythema induratum of Bazin: a histopathologic study of 101 biopsy specimens from 86 patients.
    Segura S; Pujol RM; Trindade F; Requena L
    J Am Acad Dermatol; 2008 Nov; 59(5):839-51. PubMed ID: 19119100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
    Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
    Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.